Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Hustinx

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 22, 2023
Radiotherapy modification based on artificial intelligence and radiomics applied to (<sup>18</sup>F)-fluorodeoxyglucose positron emission tomography/computed tomographyF Lucia, P Lovinfosse, U Schick, et al.
The Laryngoscope|October 20, 1998
18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patientsP Paulus, A Sambon, D Vivegnis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2021
[<sup>18</sup>F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohortP Lovinfosse, L Weekers, H Pottel, et al.
Dermatology (Basel, Switzerland)|April 25, 2000
An appraisal of 18-fluorodeoxyglucose positron emission tomography for melanoma stagingP Paquet, F Henry, T Belhocine, et al.
European Journal of Nuclear Medicine|August 3, 2014
Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysisR Hustinx, R J Dolin, F Bénard, et al.
Revue Medicale De Liege|March 14, 2003
[End of treatment evaluation in patients with aggressive non-Hodgkin's lymphoma]V Warland, G Jérusalem, R Hustinx, et al.
European Journal of Nuclear Medicine|December 1, 1996
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseP Rigo, P Paulus, B J Kaschten, et al.
European Journal of Nuclear Medicine|September 28, 2000
Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysisR Hustinx, R J Dolin, F Bénard, et al.
Revue Medicale De Liege|May 15, 2014
[Functional imaging and radiotherapy]F Lallemand, F Lakosi, R Hustinx, et al.
Nuclear Medicine and Biology|October 2, 2001
A simplified one-pot synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([18F]FHPG) and 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapyG G Shiue, C Y Shiue, R L Lee, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 22, 2023
Radiotherapy modification based on artificial intelligence and radiomics applied to (<sup>18</sup>F)-fluorodeoxyglucose positron emission tomography/computed tomographyF Lucia, P Lovinfosse, U Schick, et al.
The Laryngoscope|October 20, 1998
18FDG-PET for the assessment of primary head and neck tumors: clinical, computed tomography, and histopathological correlation in 38 patientsP Paulus, A Sambon, D Vivegnis, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 30, 2021
[<sup>18</sup>F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohortP Lovinfosse, L Weekers, H Pottel, et al.
Dermatology (Basel, Switzerland)|April 25, 2000
An appraisal of 18-fluorodeoxyglucose positron emission tomography for melanoma stagingP Paquet, F Henry, T Belhocine, et al.
European Journal of Nuclear Medicine|August 3, 2014
Erratum: Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysisR Hustinx, R J Dolin, F Bénard, et al.
Revue Medicale De Liege|March 14, 2003
[End of treatment evaluation in patients with aggressive non-Hodgkin's lymphoma]V Warland, G Jérusalem, R Hustinx, et al.
European Journal of Nuclear Medicine|December 1, 1996
Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseP Rigo, P Paulus, B J Kaschten, et al.
European Journal of Nuclear Medicine|September 28, 2000
Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysisR Hustinx, R J Dolin, F Bénard, et al.
Revue Medicale De Liege|May 15, 2014
[Functional imaging and radiotherapy]F Lallemand, F Lakosi, R Hustinx, et al.
Nuclear Medicine and Biology|October 2, 2001
A simplified one-pot synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([18F]FHPG) and 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapyG G Shiue, C Y Shiue, R L Lee, et al.
Pageof 9